Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 102 articles: HTML format

Single Articles

August 2022
1. YANG F, Zhang X, Liu F, Yao H, et al
   Rapid emergence of a PB2 D701N substitution during adaptation of an H9N2 avian influenza virus in mice.
   Arch Virol. 2022 Aug 3. pii: 10.1007/s00705-022-05536.
   PubMed     Abstract available
   
   
   
2. NAGY A, Stara M, Vodicka R, Cernikova L, et al
   Reverse-zoonotic transmission of SARS-CoV-2 lineage alpha (B.1.1.7) to great apes and exotic felids in a zoo in the Czech Republic.
   Arch Virol. 2022;167:1681-1685.
   PubMed     Abstract available
   
   
   July 2022
3. NGWE TUN MM, Luvai E, Nwe KM, Toume K, et al
   Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro.
   Arch Virol. 2022;167:1547-1557.
   PubMed     Abstract available
   
   
   
4. BAHLAWAN O, Badra R, Semaan H, Fayad N, et al
   Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon.
   Arch Virol. 2022;167:1509-1519.
   PubMed     Abstract available
   
   
   May 2022
5. TAKIZAWA N, Momose F
   A novel E198K substitution in the PA gene of influenza A virus with reduced susceptibility to baloxavir acid.
   Arch Virol. 2022 May 5. pii: 10.1007/s00705-022-05456.
   PubMed     Abstract available
   
   
   
6. PIERI M, Nicolai E, Nuccetelli M, Sarubbi S, et al
   Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
   Arch Virol. 2022;167:1285-1291.
   PubMed     Abstract available
   
   
   April 2022
7. NAGY A, Cernikova L, Stara M
   A new clade 2.3.4.4b H5N1 highly pathogenic avian influenza genotype detected in Europe in 2021.
   Arch Virol. 2022 Apr 26. pii: 10.1007/s00705-022-05442.
   PubMed     Abstract available
   
   
   
8. JIANG H, Yang T, Yang C, Lu Y, et al
   Molecular epidemiology and clinical characterization of human rhinoviruses circulating in Shanghai, 2012-2020.
   Arch Virol. 2022;167:1111-1123.
   PubMed     Abstract available
   
   
   
9. MWANGI P, Mogotsi M, Ogunbayo A, Mooko T, et al
   A decontamination strategy for resolving SARS-CoV-2 amplicon contamination in a next-generation sequencing laboratory.
   Arch Virol. 2022;167:1175-1179.
   PubMed     Abstract available
   
   
   
10. ALEJO-CANCHO I, Gual-de-Torrella A, Gallego M, Urrutikoetxea-Gutierrez M, et al
    Misidentification of the SARS-CoV-2 Mu variant using commercial mutation screening assays.
    Arch Virol. 2022;167:1141-1144.
    PubMed     Abstract available
    
    
    
11. ATIYA-NASAGI Y, Milrot E, Makdasi E, Schuster O, et al
    Development of an immunofluorescence assay for detection of SARS-CoV-2.
    Arch Virol. 2022;167:1041-1049.
    PubMed     Abstract available
    
    
    
12. COLSON P, Delerce J, Burel E, Dahan J, et al
    Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein.
    Arch Virol. 2022;167:1185-1190.
    PubMed     Abstract available
    
    
    
13. WANG Y, Li P, Lavrijsen M, Li Y, et al
    Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions.
    Arch Virol. 2022;167:1125-1130.
    PubMed     Abstract available
    
    
    March 2022
14. DA SILVA MS, Mosena ACS, Baumbach L, Demoliner M, et al
    Cattle influenza D virus in Brazil is divergent from established lineages.
    Arch Virol. 2022 Mar 17. pii: 10.1007/s00705-022-05416.
    PubMed     Abstract available
    
    
    
15. BEHESHTIROUY S, Khani E, Khiali S, Entezari-Maleki T, et al
    Investigational antiviral drugs for the treatment of COVID-19 patients.
    Arch Virol. 2022;167:751-805.
    PubMed     Abstract available
    
    
    
16. LE TB, Kim HK, Ahn MJ, Zanin M, et al
    Diagnostic performance and clinical feasibility of a novel one-step RT-qPCR assay for simultaneous detection of multiple severe acute respiratory syndrome coronaviruses.
    Arch Virol. 2022;167:871-879.
    PubMed     Abstract available
    
    
    
17. KLOC M, Uosef A, Wosik J, Kubiak JZ, et al
    Virus interactions with the actin cytoskeleton-what we know and do not know about SARS-CoV-2.
    Arch Virol. 2022;167:737-749.
    PubMed     Abstract available
    
    
    February 2022
18. SALEHI-VAZIRI M, Fazlalipour M, Seyed Khorrami SM, Azadmanesh K, et al
    The ins and outs of SARS-CoV-2 variants of concern (VOCs).
    Arch Virol. 2022;167:327-344.
    PubMed     Abstract available
    
    
    
19. COLSON P, Fantini J, Yahi N, Delerce J, et al
    Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France.
    Arch Virol. 2022;167:583-589.
    PubMed     Abstract available
    
    
    
20. WANG HX, Zhang L, Liang ZT, Nie JH, et al
    Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal.
    Arch Virol. 2022;167:459-470.
    PubMed     Abstract available
    
    
    
21. KIM Y, Jang G, Lee D, Kim N, et al
    Trypsin enhances SARS-CoV-2 infection by facilitating viral entry.
    Arch Virol. 2022;167:441-458.
    PubMed     Abstract available
    
    
    
22. ZHANG L, Guo X, Jiang H, Zhao N, et al
    Decreased incidence of acute hemorrhagic conjunctivitis associated with enhanced public health intervention during the COVID-19 epidemic in China, 2020.
    Arch Virol. 2022;167:577-581.
    PubMed     Abstract available
    
    
    
23. SHRIVASTAVA S, Mhaske ST, Modak MS, Virkar RG, et al
    Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India.
    Arch Virol. 2022;167:393-403.
    PubMed     Abstract available
    
    
    
24. SAFARI I, Elahi E
    Evolution of the SARS-CoV-2 genome and emergence of variants of concern.
    Arch Virol. 2022;167:293-305.
    PubMed     Abstract available
    
    
    January 2022
25. FUMAGALLI MJ, Capato CF, de Castro-Jorge LA, de Souza WM, et al
    Stability of SARS-CoV-2 and other airborne viruses under different stress conditions.
    Arch Virol. 2022;167:183-187.
    PubMed     Abstract available
    
    
    December 2021
26. BUITRAGO SP, Garzon-Ospina D
    Genetic diversity of SARS-CoV-2 in South America: demographic history and structuration signals.
    Arch Virol. 2021;166:3357-3371.
    PubMed     Abstract available
    
    
    
27. TRIPATHY AS, Vishwakarma S, Trimbake D, Gurav YK, et al
    Pro-inflammatory CXCL-10, TNF-alpha, IL-1beta, and IL-6: biomarkers of SARS-CoV-2 infection.
    Arch Virol. 2021;166:3301-3310.
    PubMed     Abstract available
    
    
    
28. SHI B, Song Q, Luo X, Song J, et al
    Identification of cryptic putative IRESs within the ORF encoding the nonstructural proteins of the human rhinovirus 16 genome.
    Arch Virol. 2021;166:3373-3386.
    PubMed     Abstract available
    
    
    November 2021
29. VIJAYAKUMAR P, Raut AA, Chingtham S, Murugkar HV, et al
    Proteomic analysis of differential expression of lung proteins in response to highly pathogenic avian influenza virus infection in chickens.
    Arch Virol. 2021 Nov 16. pii: 10.1007/s00705-021-05287.
    PubMed     Abstract available
    
    
    
30. TSUNEKI-TOKUNAGA A, Kondo T, Kanai K, Itagaki A, et al
    Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in Japan.
    Arch Virol. 2021 Nov 11. pii: 10.1007/s00705-021-05301.
    PubMed     Abstract available
    
    
    
31. WANG S, Liu Y, Yu L, Liang T, et al
    A strain of highly pathogenic porcine reproductive and respiratory syndrome virus: genomic characterization, pathogenicity, and construction of an infectious full-length cDNA clone.
    Arch Virol. 2021;166:3127-3141.
    PubMed     Abstract available
    
    
    
32. RASTEGAR M, Samadizadeh S, Yasaghi M, Moradi A, et al
    Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.
    Arch Virol. 2021;166:3117-3126.
    PubMed     Abstract available
    
    
    
33. DU X, Wu G, Zhu Y, Zhang S, et al
    Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China.
    Arch Virol. 2021;166:3085-3092.
    PubMed     Abstract available
    
    
    
34. RODRIGUEZ-MALDONADO AP, Vazquez-Perez JA, Cedro-Tanda A, Taboada B, et al
    Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Arch Virol. 2021;166:3173-3177.
    PubMed     Abstract available
    
    
    October 2021
35. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    PubMed     Abstract available
    
    
    
36. DOMNICH A, De Pace V, Pennati BM, Caligiuri P, et al
    Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics.
    Arch Virol. 2021;166:2825-2828.
    PubMed     Abstract available
    
    
    
37. HU J, Stojanovic J, Yasamineh S, Yasamineh P, et al
    The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
    Arch Virol. 2021;166:2649-2672.
    PubMed     Abstract available
    
    
    September 2021
38. SUN Y, Mao H, Lou X, Wang X, et al
    Molecular epidemiologic characteristics of hemagglutinin from five waves of avian influenza A (H7N9) virus infection, from 2013 to 2017, in Zhejiang Province, China.
    Arch Virol. 2021 Sep 30. pii: 10.1007/s00705-021-05233.
    PubMed     Abstract available
    
    
    
39. LAVERACK M, Tallmadge RL, Venugopalan R, Cronk B, et al
    Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Arch Virol. 2021;166:2551-2561.
    PubMed     Abstract available
    
    
    
40. NAGY A, Basiouni S, Parvin R, Hafez HM, et al
    Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
    Arch Virol. 2021;166:2541-2549.
    PubMed     Abstract available
    
    
    
41. MARCHIO A, Batejat C, Vanhomwegen J, Feher M, et al
    ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.
    Arch Virol. 2021;166:2529-2540.
    PubMed     Abstract available
    
    
    
42. ABDELWAHAB SF, Mohamed MK, Ali WY, Ali AS, et al
    Role of polymeric materials in preventing COVID-19 infection.
    Arch Virol. 2021;166:2487-2493.
    PubMed     Abstract available
    
    
    
43. BOONARKART C, Suptawiwat O, Ruangrung K, Maneechotesuwan K, et al
    Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus.
    Arch Virol. 2021;166:2579-2584.
    PubMed     Abstract available
    
    
    
44. MA Y, Jiang H, Wan Z, Li S, et al
    Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018.
    Arch Virol. 2021;166:2407-2418.
    PubMed     Abstract available
    
    
    August 2021
45. PENG J, Liu ZY, Yu XJ, Chen XY, et al
    Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.
    Arch Virol. 2021;166:2299-2303.
    PubMed     Abstract available
    
    
    
46. SHABBIR S, Raza MH, Arshad M, Khan MJ, et al
    The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Arch Virol. 2021;166:2109-2117.
    PubMed     Abstract available
    
    
    
47. HASHEMI SMA, Thijssen M, Hosseini SY, Tabarraei A, et al
    Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
    Arch Virol. 2021;166:2089-2108.
    PubMed     Abstract available
    
    
    
48. ZHANG L, Hou J, Ma FZ, Li J, et al
    The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis.
    Arch Virol. 2021;166:2071-2087.
    PubMed     Abstract available
    
    
    July 2021
49. ZHOU S, Mao N, Zhang Y, Cui A, et al
    Genetic analysis of human parainfluenza virus type 4 associated with severe acute respiratory infection in children in Luohe City, Henan Province, China, during 2017-2018.
    Arch Virol. 2021 Jul 6. pii: 10.1007/s00705-021-05154.
    PubMed     Abstract available
    
    
    
50. YUAN HW, Wen HL
    Research progress on coronavirus S proteins and their receptors.
    Arch Virol. 2021;166:1811-1817.
    PubMed     Abstract available
    
    
    
51. MIRZAEI R, Attar A, Papizadeh S, Jeda AS, et al
    The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
    Arch Virol. 2021;166:1819-1840.
    PubMed     Abstract available
    
    
    June 2021
52. ZENG MS, Yu WD, Wang HX, Xu PP, et al
    Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice.
    Arch Virol. 2021 Jun 10. pii: 10.1007/s00705-021-05112.
    PubMed     Abstract available
    
    
    
53. CHEN K, Kong M, Liu J, Jiao J, et al
    Rapid differential detection of subtype H1 and H3 swine influenza viruses using a TaqMan-MGB-based duplex one-step real-time RT-PCR assay.
    Arch Virol. 2021 Jun 6. pii: 10.1007/s00705-021-05127.
    PubMed     Abstract available
    
    
    
54. ROKIC F, Trgovec-Greif L, Sucic N, Cemeljic N, et al
    Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
    Arch Virol. 2021;166:1735-1739.
    PubMed     Abstract available
    
    
    
55. PEDREANEZ A, Mosquera-Sulbaran J, Munoz N
    SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis.
    Arch Virol. 2021;166:1565-1574.
    PubMed     Abstract available
    
    
    May 2021
56. TANG Y, Yang G, Li Y, Wang M, et al
    Protective effects of SP600125 on mice infected with H1N1 influenza A virus.
    Arch Virol. 2021 May 20. pii: 10.1007/s00705-021-05103.
    PubMed     Abstract available
    
    
    
57. SOKOLOVA AS, Yarovaya OI, Baranova DV, Galochkina AV, et al
    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus.
    Arch Virol. 2021 May 13. pii: 10.1007/s00705-021-05102.
    PubMed     Abstract available
    
    
    
58. SYLVERKEN AA, El-Duah P, Owusu M, Schneider J, et al
    Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
    Arch Virol. 2021;166:1385-1393.
    PubMed     Abstract available
    
    
    April 2021
59. GONZALEZ-GARCIA LD, Martinez-Castillo M, Vargas-Pavia TA, Ulloa-Aguilar JM, et al
    Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.
    Arch Virol. 2021;166:1177-1182.
    PubMed     Abstract available
    
    
    March 2021
60. ZINYAKOV NG, Sosipatorova VY, Andriyasov AV, Ovchinnikova EV, et al
    Genetic analysis of genotype G57 H9N2 avian influenza virus isolate A/chicken/Tajikistan/2379/2018 recovered in Central Asia.
    Arch Virol. 2021 Mar 19. pii: 10.1007/s00705-021-05011.
    PubMed     Abstract available
    
    
    
61. WOUK J, Rechenchoski DZ, Rodrigues BCD, Ribelato EV, et al
    Viral infections and their relationship to neurological disorders.
    Arch Virol. 2021;166:733-753.
    PubMed     Abstract available
    
    
    
62. DOWLATSHAHI S, Shabani E, Abdekhodaie MJ
    Serological assays and host antibody detection in coronavirus-related disease diagnosis.
    Arch Virol. 2021;166:715-731.
    PubMed     Abstract available
    
    
    
63. DABBOUS HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, et al
    Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.
    Arch Virol. 2021;166:949-954.
    PubMed     Abstract available
    
    
    
64. VERMA J, Subbarao N
    A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
    Arch Virol. 2021;166:697-714.
    PubMed     Abstract available
    
    
    
65. SARKAR R, Mitra S, Chandra P, Saha P, et al
    Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.
    Arch Virol. 2021;166:801-812.
    PubMed     Abstract available
    
    
    
66. HEMMAT N, Asadzadeh Z, Ahangar NK, Alemohammad H, et al
    The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
    Arch Virol. 2021;166:675-696.
    PubMed     Abstract available
    
    
    February 2021
67. YANG F, Xiao Y, Liu F, Yao H, et al
    Isolation and characterization of two novel reassortant H5N6 avian influenza viruses from waterfowl in eastern China.
    Arch Virol. 2021 Feb 17. pii: 10.1007/s00705-021-04995.
    PubMed     Abstract available
    
    
    
68. LI Y, Hu J, Lei J, Fan W, et al
    Development and application of a novel triplex protein microarray method for rapid detection of antibodies against avian influenza virus, Newcastle disease virus, and avian infectious bronchitis virus.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04962.
    PubMed     Abstract available
    
    
    
69. TSUNEKI-TOKUNAGA A, Kanai K, Itagaki A, Tsuchie H, et al
    Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04976.
    PubMed     Abstract available
    
    
    January 2021
70. ALLKOFER A, Garvey M, Ryan E, Lyons R, et al
    Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
    Arch Virol. 2021 Jan 7. pii: 10.1007/s00705-020-04846.
    PubMed     Abstract available
    
    
    
71. SABBAGHI A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, et al
    Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Arch Virol. 2021 Jan 6. pii: 10.1007/s00705-020-04900.
    PubMed     Abstract available
    
    
    
72. NG KT, Takebe Y, Kamarulzaman A, Tee KK, et al
    Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution.
    Arch Virol. 2021;166:225-229.
    PubMed     Abstract available
    
    
    
73. ARANCIO W
    ceRNA analysis of SARS-CoV-2.
    Arch Virol. 2021;166:271-274.
    PubMed     Abstract available
    
    
    
74. MOSQUERA-SULBARAN JA, Hernandez-Fonseca H
    Tetracycline and viruses: a possible treatment for COVID-19?
    Arch Virol. 2021;166:1-7.
    PubMed     Abstract available
    
    
    December 2020
75. REHMAN S, Mahmood T, Aziz E, Batool R, et al
    Identification of novel mutations in SARS-COV-2 isolates from Turkey.
    Arch Virol. 2020;165:2937-2944.
    PubMed     Abstract available
    
    
    November 2020
76. YANG X, Liang Y, Bamunuarachchi G, Xu Y, et al
    miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
    Arch Virol. 2020 Nov 18. pii: 10.1007/s00705-020-04877.
    PubMed     Abstract available
    
    
    
77. LIU B, Wang Y, Liu Y, Chen Y, et al
    Molecular evolution and characterization of hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 viruses isolated in Beijing, China, during the 2017-2018 and 2018-2019 influenza seasons.
    Arch Virol. 2020 Nov 3. pii: 10.1007/s00705-020-04869.
    PubMed     Abstract available
    
    
    
78. DADAR M, Fakhri Y, Bjorklund G, Shahali Y, et al
    The association between the incidence of COVID-19 and the distance from the virus epicenter in Iran.
    Arch Virol. 2020;165:2555-2560.
    PubMed     Abstract available
    
    
    
79. SHAMIM S, Khan M, Kharaba ZJ, Ijaz M, et al
    Potential strategies for combating COVID-19.
    Arch Virol. 2020;165:2419-2438.
    PubMed     Abstract available
    
    
    October 2020
80. GROHN S, Heinimaki S, Tamminen K, Blazevic V, et al
    Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform.
    Arch Virol. 2020 Oct 16. pii: 10.1007/s00705-020-04847.
    PubMed     Abstract available
    
    
    
81. CAROSSINO M, Ip HS, Richt JA, Shultz K, et al
    Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
    Arch Virol. 2020;165:2373-2377.
    PubMed     Abstract available
    
    
    
82. GALLAHER WR
    A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
    Arch Virol. 2020;165:2341-2348.
    PubMed     Abstract available
    
    
    
83. JANG Y, Seo SH
    Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
    Arch Virol. 2020;165:2205-2211.
    PubMed     Abstract available
    
    
    September 2020
84. GARCES-AYALA F, Araiza-Rodriguez A, Mendieta-Condado E, Rodriguez-Maldonado AP, et al
    Full genome sequence of the first SARS-CoV-2 detected in Mexico.
    Arch Virol. 2020;165:2095-2098.
    PubMed     Abstract available
    
    
    August 2020
85. KETKLAO S, Boonarkart C, Phakaratsakul S, Auewarakul P, et al
    Responses to the Sb epitope contributed to antigenic drift of the influenza A 2009 H1N1 virus.
    Arch Virol. 2020 Aug 11. pii: 10.1007/s00705-020-04758.
    PubMed     Abstract available
    
    
    
86. LIMA WG, Brito JCM, Overhage J, Nizer WSDC, et al
    The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Arch Virol. 2020;165:1729-1737.
    PubMed     Abstract available
    
    
    
87. MCIVER DJ, Silithammavong S, Theppangna W, Gillis A, et al
    Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents.
    Arch Virol. 2020;165:1869-1875.
    PubMed     Abstract available
    
    
    July 2020
88. DA COSTA VG, Moreli ML, Saivish MV
    The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    Arch Virol. 2020;165:1517-1526.
    PubMed     Abstract available
    
    
    June 2020
89. KOLOSOVA NP, Ilyicheva TN, Danilenko AV, Svyatchenko SV, et al
    Severe cases of seasonal influenza and detection of seasonal A(H1N2) in Russia in 2018-2019.
    Arch Virol. 2020 Jun 10. pii: 10.1007/s00705-020-04699.
    PubMed     Abstract available
    
    
    May 2020
90. YUN KW, Choi EH, Lee HJ
    Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea.
    Arch Virol. 2020;165:1069-1077.
    PubMed     Abstract available
    
    
    
91. LI H, Cao L, Zhang Y, Ren H, et al
    Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Arch Virol. 2020;165:1057-1067.
    PubMed     Abstract available
    
    
    April 2020
92. ARBI M, Souiai O, Rego N, Larbi I, et al
    Historical origins and zoonotic potential of avian influenza virus H9N2 in Tunisia revealed by Bayesian analysis and molecular characterization.
    Arch Virol. 2020 Apr 25. pii: 10.1007/s00705-020-04624.
    PubMed     Abstract available
    
    
    
93. YEHIA N, Hassan WMM, Sedeek A, Elhusseiny MH, et al
    Genetic variability of avian influenza virus subtype H5N8 in Egypt in 2017 and 2018.
    Arch Virol. 2020 Apr 13. pii: 10.1007/s00705-020-04621.
    PubMed     Abstract available
    
    
    March 2020
94. LIMSUWAT N, Boonarkart C, Phakaratsakul S, Suptawiwat O, et al
    Influence of cellular lipid content on influenza A virus replication.
    Arch Virol. 2020 Mar 29. pii: 10.1007/s00705-020-04596.
    PubMed     Abstract available
    
    
    
95. JANG Y, Seo T, Seo SH
    Higher virulence of swine H1N2 influenza viruses containing avian-origin HA and 2009 pandemic PA and NP in pigs and mice.
    Arch Virol. 2020 Mar 28. pii: 10.1007/s00705-020-04572.
    PubMed     Abstract available
    
    
    
96. YANG F, Xiao Y, Xu L, Liu F, et al
    Development of an antigen-capture enzyme-linked immunosorbent assay and immunochromatographic strip based on monoclonal antibodies for detection of H6 avian influenza viruses.
    Arch Virol. 2020 Mar 27. pii: 10.1007/s00705-020-04602.
    PubMed     Abstract available
    
    
    
97. SIMMONDS P, Gorbalenya AE, Harvala H, Hovi T, et al
    Recommendations for the nomenclature of enteroviruses and rhinoviruses.
    Arch Virol. 2020;165:793-797.
    PubMed     Abstract available
    
    
    February 2020
98. RAMIREZ-SALINAS GL, Garcia-Machorro J, Rojas-Hernandez S, Campos-Rodriguez R, et al
    Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
    Arch Virol. 2020 Feb 14. pii: 10.1007/s00705-020-04537.
    PubMed     Abstract available
    
    
    January 2020
99. KHALIL AM, Nishi N, Kojima I, Fukunaga W, et al
    Transition in genetic constellations of H3N8 and H4N6 low-pathogenic avian influenza viruses isolated from an overwintering site in Japan throughout different winter seasons.
    Arch Virol. 2020 Jan 10. pii: 10.1007/s00705-019-04519.
    PubMed     Abstract available
    
    
    November 2019
100. EVSEENKO VA, Svyatchenko SV, Kolosova NP, Kovrizhkina VL, et al
     Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase.
     Arch Virol. 2019 Nov 19. pii: 10.1007/s00705-019-04465.
     PubMed     Abstract available
     
     
     
101. TWABELA AT, Okamatsu M, Tshilenge GM, Mpiana S, et al
     Molecular, antigenic, and pathogenic characterization of H5N8 highly pathogenic avian influenza viruses isolated in the Democratic Republic of Congo in 2017.
     Arch Virol. 2019 Nov 9. pii: 10.1007/s00705-019-04456.
     PubMed     Abstract available
     
     
     
102. ZELL R, Groth M, Krumbholz A, Lange J, et al
     Displacement of the Gent/1999 human-like swine H1N2 influenza A virus lineage by novel H1N2 reassortants in Germany.
     Arch Virol. 2019 Nov 6. pii: 10.1007/s00705-019-04457.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: